Back
Arcutis Biotherapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Buy
66
ARQT
Arcutis Biotherapeutics
Last Price:
$15.27
Seasonality Move:
71.61%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight buying pressure.
Arcutis Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.58 | Buy |
| 20-day SMA: | 12.68 | Buy |
| 50-day SMA: | 10.71 | Buy |
| 200-day SMA: | 9.85 | Buy |
| 8-day EMA: | 13.78 | Buy |
| 20-day EMA: | 12.76 | Buy |
| 50-day EMA: | 11.43 | Buy |
| 200-day EMA: | 9.8 | Buy |
Arcutis Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.02 | Buy |
| Relative Strength Index (14 RSI): | 67.53 | Buy |
| Chaikin Money Flow: | 32396 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.56 - 13.66) | Buy |
| Bollinger Bands (100): | (8.75 - 11.75) | Buy |
Arcutis Biotherapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arcutis Biotherapeutics Stock
Is Arcutis Biotherapeutics Stock a Buy?
-
Arcutis Biotherapeutics share price is 14.99 while ARQT 8-day simple moving average is 13.58, which is a Buy signal.
-
The stock price of ARQT is 14.99 while Arcutis Biotherapeutics 20-day SMA is 12.68, which makes it a Buy.
-
Arcutis Biotherapeutics 50-day simple moving average is 10.71 while ARQT share price is 14.99, making it a Buy technically.
-
ARQT stock price is 14.99 and Arcutis Biotherapeutics 200-day simple moving average is 9.85, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Buy
66
Arcutis Biotherapeutics (ARQT)
is a Buy
Is Arcutis Biotherapeutics a Buy or a Sell?
-
Arcutis Biotherapeutics stock is rated a BuyThe current Arcutis Biotherapeutics [ARQT] share price is $14.99. The Score for ARQT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Arcutis Biotherapeutics Stock Info
Market Cap:
1.8B
Price in USD:
14.99
Share Volume:
5.2M
Arcutis Biotherapeutics 52-Week Range
52-Week High:
15.79
52-Week Low:
2.60
Buy
66
Arcutis Biotherapeutics (ARQT)
is a Buy
Arcutis Biotherapeutics Share Price Forecast
-
What is the Arcutis Biotherapeutics stock price today?The Arcutis Biotherapeutics stock price is 14.99 USD today.
-
Will ARQT stock go up or go down?Arcutis Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Arcutis Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics is not overvalued.
Is Arcutis Biotherapeutics Stock a Buy?
-
Arcutis Biotherapeutics share price is 14.99 while ARQT 8-day exponential moving average is 13.78, which is a Buy signal.
-
The stock price of ARQT is 14.99 while Arcutis Biotherapeutics 20-day EMA is 12.76, which makes it a Buy.
-
Arcutis Biotherapeutics 50-day exponential moving average is 11.43 while ARQT share price is 14.99, making it a Buy technically.
-
ARQT stock price is 14.99 and Arcutis Biotherapeutics 200-day simple moving average is 9.80, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics
Is Arcutis Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.
Technical Analysis of Arcutis Biotherapeutics
Should I short Arcutis Biotherapeutics stock?
-
ARQT Moving Average Covergence Divergence (MACD) indicator is 1.02, suggesting Arcutis Biotherapeutics is a Buy
-
Arcutis Biotherapeutics Relative Strength Index (RSI) is 67.53, which suggest Arcutis Biotherapeutics is overbought
-
The Bollinger Bands (25) for Arcutis Biotherapeutics is (10.56 - 13.66), which suggest Arcutis Biotherapeutics is a Buy
-
The Bollinger Bands (100) for Arcutis Biotherapeutics is (8.75 - 11.75), which suggest Arcutis Biotherapeutics is a Buy
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.